Chief Financial Officer @ (July 2022 - August 2024)
Chief Financial Officer @ (October 2021 - July 2022)
Vice President Finance and Administration @ Harpoon Therapeutics (July 2018 - October 2021)
VP, Finance and Administration @ Immune Design (April 2015 - February 2018)
Corporate Controller and Senior Director of Finance @ (July 2013 - April 2015)
Corporate Controller and Director of Finance @ (May 2011 - July 2013)
Corporate Controller @ (June 2010 - June 2011)
Manager - Financial Planning and Analysis @ (May 2008 - June 2010)
Manager - Audit @ (October 2002 - May 2008)
Christopher Whitmore Education
UC Santa Barbara
BA (Business, Economics, Accounting, Sports Management)
Christopher Whitmore Skills
Sarbanes-Oxley Act
Accounting
Auditing
Due Diligence
Finance
Financial Analysis
Financial Modeling
Financial Planning
Financial Reporting
Management
Mergers & Acquisitions
SEC Filings
Strategic Planning
Budgets
Sarbanes Oxley Act
Mergers and Acquisitions
Christopher Whitmore Summary
Christopher Whitmore, based in California, United States, is currently a Chief Financial Officer at Ray Therapeutics, Inc.. Christopher Whitmore brings experience from previous roles at Immune-Onc Therapeutics, Notable, Harpoon Therapeutics and Immune Design. Christopher Whitmore holds a BA in Business, Economics, Accounting, Sports Management @ UC Santa Barbara. With a robust skill set that includes Sarbanes-Oxley Act, Accounting, Auditing, Due Diligence, Finance and more. Christopher Whitmore has 1 mobile phone numbers on RocketReach.
Looking for a different Christopher Whitmore?
Find contact details for 700 million professionals.